Concepedia

Mark F. Harper

MF

Statistics

Publications

5

Citations

434

H-Index

5

Active since

1992

Affiliations

University of North Carolina at Chapel Hill(Current)

Mark F. Harper is an author at University of North Carolina at Chapel Hill specializing in life sciences, biochemistry, and pharmacology.

Publications per year

1992–1998

5

Publications

5

"Anticardiolipin" autoantibodies recognize beta2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding.

Robert Roubey, Robert A. Eisenberg, Mark F. Harper et al. · The Journal of Immunology · 1995 · 333 citations · Full text

, , +16

Characterization of beta2-glycoprotein I binding to phospholipid membranes.

Mark F. Harper, Polly Hayes, B R Lentz et al. · PubMed · 1998 · 39 citations

, , +17

Acyl-CoA: cholesterol O-acyl transferase (ACAT) inhibitors. 1. 2-(Alkylthio)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT

Neil V. Harris, Andrew W. Bridge, Raymond C. Bush et al. · Journal of Medicinal Chemistry · 1992 · 38 citations · Full text

, , +16

Mechanism and stereochemistry of the enzyme-catalysed formation of a 2,2-dimethylchromene ring from a prenylated phenol: conversion of rot-2′-enonic acid into deguelin by deguelin cyclase

Prabha Bhandari, Leslie Crombie, Mark F. Harper et al. · Journal of the Chemical Society Perkin Transactions 1 · 1992 · 12 citations

, , +7

Selective endothelin A receptor antagonists. 2. Discovery and structure-activity relationships of 5-ketopentanoic acid derivatives

Peter C. Astles, Thomas J. Brown, Neil V. Harris et al. · European Journal of Medicinal Chemistry · 1997 · 12 citations

, , +14

1–5 of 5